Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)
Clinical trial NCT03976323 · COMPLETED
Trial details
- NCT number
- NCT03976323
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-28
- Primary completion
- 2024-02-07
- Enrollment
- 1003
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.